Preoperative Evaluation and Preparation for Lung Transplantation

[1]  Josef Stehlik,et al.  The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  L. Shaw,et al.  Preoperative Mild-to-Moderate Coronary Artery Disease Does Not Affect Long-Term Outcomes of Lung Transplantation , 2014, Transplantation.

[3]  L. Shaw,et al.  Coronary Revascularization in Lung Transplant Recipients With Concomitant Coronary Artery Disease , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  J. Pilewski,et al.  Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. , 2013, The Journal of thoracic and cardiovascular surgery.

[5]  M. Hoeper,et al.  Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. , 2012, The Journal of thoracic and cardiovascular surgery.

[6]  C. Merlo,et al.  Lung transplantation in patients 70 years old or older: have outcomes changed after implementation of the lung allocation score? , 2012, The Journal of thoracic and cardiovascular surgery.

[7]  T. Welte,et al.  Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. , 2012, American journal of respiratory and critical care medicine.

[8]  E. Decullier,et al.  Sirolimus and secondary skin-cancer prevention in kidney transplantation. , 2012, The New England journal of medicine.

[9]  H. Nemeh,et al.  Timing of basiliximab induction and development of acute rejection in lung transplant patients. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  J. Pilewski,et al.  Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. , 2011, The Annals of thoracic surgery.

[11]  M. Dew,et al.  Five-year outcomes with alemtuzumab induction after lung transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  J. Lordan,et al.  Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  E. Blackstone,et al.  Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. , 2010, The Journal of thoracic and cardiovascular surgery.

[14]  Y. Castier,et al.  Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary Fibrosis , 2009, Annals of Internal Medicine.

[15]  M. Bacchetta,et al.  Obesity and underweight are associated with an increased risk of death after lung transplantation. , 2009, American journal of respiratory and critical care medicine.

[16]  P. Grossi,et al.  Successful Lung Transplantation in an HIV‐ and HBV‐Positive Patient with Cystic Fibrosis , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  M. Russo,et al.  Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. , 2009, Chest.

[18]  J. Zijlstra,et al.  Lung transplantation for ventilator-dependent respiratory failure. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  J. Orens,et al.  General overview of lung transplantation and review of organ allocation. , 2009, Proceedings of the American Thoracic Society.

[20]  M. Manns,et al.  Indications for and Outcomes After Combined Lung and Liver Transplantation: A Single-Center Experience on 13 Consecutive Cases , 2008, Transplantation.

[21]  M. Steele,et al.  Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  A. Mehta,et al.  Outcomes after lung transplantation in patients with chronic hepatitis C virus infection. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  D. Paterson,et al.  Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  P. Morris,et al.  Alemtuzumab (Campath-1H): A Systematic Review in Organ Transplantation , 2006, Transplantation.

[25]  F L Grover,et al.  Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  R. Aris,et al.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation , 2006, Thorax.

[27]  Jens Gottlieb,et al.  Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. , 2006, The Journal of thoracic and cardiovascular surgery.

[28]  M. Steele,et al.  Impact of Lung Transplant Operation on Bronchiolitis Obliterans Syndrome in Patients with Chronic Obstructive Pulmonary Disease , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  T. Egan,et al.  Tobacco and alcohol use in lung transplant candidates and recipients , 2005, Clinical transplantation.

[30]  P. Mazzone,et al.  Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  R. Cornwell,et al.  Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. , 2003, Chest.

[32]  Marshall Hertz,et al.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  P. Gilligan,et al.  Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. , 2001, American journal of respiratory and critical care medicine.

[34]  J. Byrd,et al.  Campath-1H monoclonal antibody therapy , 2000, Current opinion in oncology.

[35]  A. Glanville,et al.  The spectrum of mycobacterial infection after lung transplantation. , 1999, American journal of respiratory and critical care medicine.

[36]  E. Cantu,et al.  Salvage by volume reduction of chronic allograft rejection in emphysema. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  F. Martinez,et al.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[38]  R. Merion,et al.  Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. , 1998, Transplantation.

[39]  F. Detterbeck,et al.  Lung transplantation after previous thoracic surgical procedures. , 1995, The Annals of thoracic surgery.

[40]  M. Pasque,et al.  Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. , 1992, The Journal of thoracic and cardiovascular surgery.

[41]  J. Cooper,et al.  Double-lung transplant for advanced chronic obstructive lung disease. , 1989, The American review of respiratory disease.

[42]  J. Hardy,et al.  LUNG HOMOTRANSPLANTATION IN MAN. , 1963, JAMA.

[43]  A. Hayanga,et al.  Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease. , 2015, The Journal of thoracic and cardiovascular surgery.

[44]  Robert M. Jones,et al.  CORONARY ARTERY DISEASE Original Studies Prevalence of Obstructive Coronary Artery Disease in Patients Undergoing Lung Transplantation: Case Series and Review of the Literature , 2014 .

[45]  J. Lunz,et al.  Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  P. Tarsia,et al.  Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation. , 2013, Interactive cardiovascular and thoracic surgery.